Gene delivery of neurturin to putamen and substantia nigra in <scp>P</scp>arkinson disease: A double‐blind, randomized, controlled trial

C. Warren Olanow, Raymond T. Bartus, Tiffany Baumann, Stewart A. Factor, Nicholas M. Boulis, Mark Stacy, Dennis A. Turner, William J. Marks, Paul Larson, Phillip A. Starr, Joseph Jankovic, Richard K. Simpson, Ray L. Watts, Barton L. Guthrie, Kathleen L. Poston, Jaimie M. Henderson, Matthew Stern, Gordon H. Baltuch, Christopher G. Goetz, Christopher D. Herzog, Jeffrey H. Kordower, Ron L. Alterman, Andrés M. Lozano, Anthony E. LangAnnals 2015 · DOI

Abstract

AAV2-neurturin delivery to the putamen and substantia nigra bilaterally in PD was not superior to sham surgery. The procedure was well tolerated, and there were no clinically significant adverse events related to AAV2-neurturin.
BibTeX
@article{olanow2015gene,
  author = {C. Warren Olanow and Raymond T. Bartus and Tiffany Baumann and Stewart A. Factor and Nicholas M. Boulis and Mark Stacy and Dennis A. Turner and William J. Marks and Paul Larson and Phillip A. Starr and Joseph Jankovic and Richard K. Simpson and Ray L. Watts and Barton L. Guthrie and Kathleen L. Poston and Jaimie M. Henderson and Matthew Stern and Gordon H. Baltuch and Christopher G. Goetz and Christopher D. Herzog and Jeffrey H. Kordower and Ron L. Alterman and Andrés M. Lozano and Anthony E. Lang},
  title = {{Gene delivery of neurturin to putamen and substantia nigra in <scp>P</scp>arkinson disease: A double‐blind, randomized, controlled trial}},
  journal = {Annals},
  year = {2015},
  doi = {10.1002/ana.24436},
}

Loading related content...

Figure